Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement: Love SC et al.

European Journal of Neurology 2010, 17 (Suppl. 2): 9–3
doi:10.1111/j.1468-1331.2010.03126.

Authors
S. C. Love a,

I. Novak b,

M. Kentish c,

K. Desloovere d.

F. Heinen e,

G. Molenaers f,

S. O. Flaherty g

and H. K. Graham h

Author Details

a Centre for Musculoskeletal Studies, University of Western Australia, Princess Margaret Hospital, Western Australia;

b Cerebral Palsy Institute, School of Medicine, University of Notre Dame Australia, Darlinghurst, Sydney, NSW;

c Queensland Cerebral Palsy Health Service, Department of Paediatric Rehabilitation, Royal Children’s Hospital, Brisbane, QLD, Australia;

d Department of Rehabilitation Sciences, KUL, Leuven, Belgium;

e Paediatric Neurology & Developmental Medicine, Children’s Hospital University of Munich, Munich, Germany;

f Department of Musculoskeletal Sciences, KUL, Leuven, Belgium;

g Rehabilitation Dept, Children’s Hospital at Westmead, Westmead, NSW, Australia; and

h University of Melbourne, Department of Orthopaedics and Murdoch Children’s Research Institute, The Royal Children’s Hospital, Parkville, Vic., Australia

Please click here!